Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Meta Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen

What is the purpose of this trial?

To compare the efficacy of AM0010 in combination with FOLFOX versus FOLFOX alone in patients with metastatic pancreatic cancer as measured by overall survival.



ARMO Biosciences

Dates: 08/10/2017 - 01/30/2019

Last Updated: 08/11/2017

Study HIC#: 1611018625

Get Involved

For more information about this study, contact:
Kamil Sadowski
203-785-6666
kamil.sadowski@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Jill Lacy

Principal Investigator

Sub-Investigators